Epigenetic pathway inhibitors represent potential drugs for treating pancreatic and bronchial neuroendocrine tumors

Cancer is associated with alterations in epigenetic mechanisms such as histone modifications and methylation of DNA, and inhibitors targeting epigenetic mechanisms represent a novel class of anti-cancer drugs. Neuroendocrine tumors (NETs) of the pancreas (PNETs) and bronchus (BNETs), which may have...

Descripción completa

Detalles Bibliográficos
Autores principales: Lines, K E, Stevenson, M, Filippakopoulos, P, Müller, S, Lockstone, H E, Wright, B, Grozinsky-Glasberg, S, Grossman, A B, Knapp, S, Buck, D, Bountra, C, Thakker, R V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523063/
https://www.ncbi.nlm.nih.gov/pubmed/28504695
http://dx.doi.org/10.1038/oncsis.2017.30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523063/
https://www.ncbi.nlm.nih.gov/pubmed/28504695
http://dx.doi.org/10.1038/oncsis.2017.30

Ejemplares similares